A Clinical Trial to Investigate the Efficacy and Safety of a Plant-based Cetylated Fatty Acids (CFA) on Knee Pain and Stiffness in Healthy Adults With Persistent Knee Pain
In plain words A study of cetylated Fatty Acids in people 35 to 75, run by Everwell Health. It plans to enroll about 80 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 35 to 75; healthy volunteers accepted. Conditions: Joint Health; Mobility; Knee Pain.
- Males \& females between 35 and 75 years of age
- Females not of child-bearing potential, defined as those who have undergone a sterilization procedure (e.g.
- Hormonal contraceptives including oral contraceptives, hormone birth control patch (Ortho Evra), vaginal contraceptive ring (NuvaRing), injectable contraceptives (Depo-Provera, Lunelle), or hormone implant (Norplant System)
- Double-barrier method
15 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Plant-derived cetylated fatty acids (CFA); Placebo
Registered summary
The goal of this clinical trial is to investigate the efficacy and safety of plant-derived cetylated fatty acids (CFA) on joint health and mobility in adults with persistent knee pain. The main question it aims to answer is what is the change from baseline to day 42 in knee joint health, as assessed by the KOOS pain sub-scale scores, between plant-derived cetylated fatty acids (CFA) and placebo? Researchers will compare plant-derived cetylated fatty acids (CFA) with placebo to evaluate its effects on joint health, mobility, pain, and stiffness. The full summary is on the listing.
Where, as registered
No US site; Canada (1).